Srdan Verstovsek, M.D., Ph.D.

Dr. Verstovsek was Professor of Medicine and hematologist-oncologist at MD Anderson Cancer Center in Houston, Texas. He is a global leader in myeloproliferative neoplasms (MPN) and the Founder/Director of the largest single institution MPN Clinical Research Center worldwide. Dr. Verstovsek has achieved international acclaim for his leadership in developing landmark MPN therapeutics and have received several awards. His contributions have been globally recognized with numerous invitations as expert speaker/educator/Chair at the most significant national/international conferences. Currently, Dr. Verstovsek is Chief Medical Officer, Kartos Therapeutics, Redwood City, CA, USA.